Apr 22, 2022
Lisa Schnirring | News Editor | CIDRAP NewsApr 22, 2022Also, the WHO revised its assessment of remdesivir, recommending it for mild or moderate infections in high-risk groups.Read More
Lisa Schnirring | News Editor | CIDRAP NewsApr 22, 2022Also, the WHO revised its assessment of remdesivir, recommending it for mild or moderate infections in high-risk groups.Read More